A new ad campaign to encourage people to quit… Make quitting an important component of your New Year resolution. as my friend Cyril, a smoker, said himself: No good comes from smoking. The question is: Wouldn’t you want to stop if you could see
Read more →
by Kazeem Olalekan MRPharmS In our latest interview, Kazeem chats with Cyril Siou – Community Pharmacist. This interview effectively introduces the reader to Cyril – the man. He was one of the people that said yes when I presented him with a blank canvass of what
Read more →
by Kazeem Olalekan MRPharmS I was at the Pharmacy Management National Forum held on Thursday 15 November 2013 at Novotel in Hammersmith. This is the second instalment of my conference notes. In my first instalment, I eluded to what we are doing in Wessex around transfer of care. I will be
Read more →
by Kazeem Olalekan MRPharmS It is with great pleasure that I introduce the subject of our most current case study. I have been busy interviewing this amazing community pharmacist. Her name is Patricia Lee, Community Pharmacist at Tesco-in-store pharmacy at Bursledon Towers, mother to Lucas, wife to
Read more →
by Kazeem Olalekan MRPharmS One of the cornerstones of pharmaceutical research (and indeed any other scientific research) is dissemination. If you have done the work, why would you not want people to know about it? It is with that in mind that I congratulate the Chief Pharmaceutical
Read more →
by Kazeem Olalekan MRPharmS When I talk about Pharmacy being the profession of aspiration, some of my colleagues cringe! I understand why they might. It fits into an old narrative that goes something like this: we are pharmacists because we failed in our bid to get into
Read more →
by Kazeem Olalekan MRPharmS I took my daughter to the optician recently and it got me thinking: What an amazing thing: vision! We all need it and all the better if it is a good one. In October last year, I wrote a blog about the 2020
Read more →
by Kazeem Olalekan MRPharmS If you follow our blog, you will know that we are passionate about apps (you know..iphone (OS), android and possibly others – I know Microsoft is working very hard to narrow the gap on its rivals – so when we get our hands
Read more →
by Kazeem Olalekan MRPharmS I cannot help but notice, with concern, the latest news item by in which Boots the Chemist is to offer ‘3 for 2’ mix and match promotion across its entire healthcare range this week (link). Clearly the customer will welcome an opportunity to pay
Read more →
by Kazeem Olalekan MRPharmS In August a number of communications on medicines safety were sent out to healthcare professionals via the MHRA. If you missed any of it then here are the summary. Full details are available on the MHRA website. Number 1: Number 2: Number 3:
Read more →
by Kazeem Olalekan MRPharmS This July we have posted our 6th Case Study. We are quite proud about this one. Kazeem conducted an interview with Sue Gough, a Critical Evaluation Pharmacist at University Hospitals Southampton NHS Foundation Trust. It provides an insight into what these breeds of
Read more →
by Kazeem Olalekan MRPharmS I was delighted by the news that the National Paediatric Surgery Reviews has opted for option B which means that University Hospital Southampton NHS Foundation Trust (UHSFT) in partnership with Oxford Radcliffe Hospitals NHS Trust will continue to deliver first class quality service
Read more →
by Kazeem Olalekan MRPharmS The latest update to MUR requirements (1) which applied from the 1st of July is refreshing. If I was commissioning the service for the first time, this is what it might look like. Nonetheless, evolution is not a bad thing. The
Read more →
by Kazeem Olalekan Clearly I am excitable. When I learnt of the new iphone and Android app from the nice folks at NICE, then you know what is coming. Hee Heee Heeeeeeeeeeeeeeeeeeeeee Haaaaaaaaaaaah! I’ll tell you why. I spent my top dollar about a year ago on
Read more →
by Kazeem Olalekan Attention has just been drawn to the Drug Safety Update on Febuxostat (Adenuric) via the PJOnline website. In summary, there have been rare but serious reports of hypersensitivity reactions, including Stevens-Johnson syndrome and acute anaphylactic shock, with febuxostat (Adenuric). Febuxostat must be stopped immediately
Read more →
